rs201883228
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_004260.4(RECQL4):c.2237C>T(p.Ala746Val) variant causes a missense change. The variant allele was found at a frequency of 0.000382 in 1,609,684 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A746T) has been classified as Uncertain significance.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 88AN: 152250Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000231 AC: 56AN: 242430 AF XY: 0.000188 show subpopulations
GnomAD4 exome AF: 0.000362 AC: 527AN: 1457314Hom.: 0 Cov.: 47 AF XY: 0.000342 AC XY: 248AN XY: 725128 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000578 AC: 88AN: 152370Hom.: 1 Cov.: 33 AF XY: 0.000617 AC XY: 46AN XY: 74512 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2237C>T (p.A746V) alteration is located in exon 14 (coding exon 14) of the RECQL4 gene. This alteration results from a C to T substitution at nucleotide position 2237, causing the alanine (A) at amino acid position 746 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Reported in an individual with sagittal synostosis, but further clinical information, information on the zygosity or presence of a second RECQL4 variant, and familial segregation information were not included (Sewda et al., 2019); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31555317, 30651579) -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.2237C>T (p.Ala746Val) missense change has a maximum subpopulation frequency of 0.082% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools are inconclusive about a benign or pathogenic effect of this variant on protein function, and to our knowledge functional studies have not been performed. This variant was reported in an individual with nonsyndromic saggital craniosynostosis, however the zygosity or identification of a second variant was not indicated (PMID: 30651579). In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 746 of the RECQL4 protein (p.Ala746Val). This variant is present in population databases (rs201883228, gnomAD 0.08%). This missense change has been observed in individual(s) with sagittal craniosynostosis (PMID: 30651579). ClinVar contains an entry for this variant (Variation ID: 239719). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
RECQL4-related disorder Uncertain:1
The RECQL4 c.2237C>T variant is predicted to result in the amino acid substitution p.Ala746Val. This variant was reported in an individual with nonsyndromic sagittal craniosynostosis; however, the zygosity or presence of a second variant was not specified (Sewda et al. 2019. PubMed ID: 30651579). This variant is reported in 0.082% of alleles in individuals of Latino descent in gnomAD and in ClinVar this variant has been interpreted as uncertain (https://ncbi.nlm.nih.gov/clinvar/variation/239719/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at